Sucrosomial® Iron: A New Generation Iron for Improving Oral Supplementation
Open accessThe DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Iron deficiency (ID) is usually treated with oral iron salts, but up to 50% of patients complain of gastrointestinal side effects, leading to reduced compliance with treatment. Intravenous (IV) iron formulations are increasingly safe, but there is still a risk of infusion, hypersensitivity reactions and the need for venous access and infusion monitoring. Sucrosomial® Iron (SI) is an innovative oral iron formulation in which ferric pyrophosphate is protected by a phospholipid bilayer plus a sucrester matrix (sucrosome), which is absorbed through para-cellular and trans-cellular routes (M cells). This confers SI’s unique structural, physicochemical and pharmacokinetic characteristics, together with its high iron bioavailability and excellent gastrointestinal tolerance. The analysis of the available evidence supports oral SI iron as a valid option for ID treatment, which is more efficacious and tolerable than oral iron salts. SI has also demonstrated a similar effectiveness, with lower risks, in patients usually receiving IV iron (e.g., chronic kidney disease, cancer, bariatric surgery). Thus, oral SI emerges as a valuable first option for treating ID, especially for subjects with intolerance to iron salts or those for whom iron salts are inefficacious. Moreover, SI should also be considered as an alternative to IV iron for initial and/or maintenance treatment in different patient populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Prevalence of iron deficiency across pathologies. (Data taken from references [5,6,7,8,9,10,11,12,13]).](https://figures.cochat.ai/paper-figures/9feb25a1d42c49aca53a32d1f6c2c214/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-1.jpg)


![Figure 4 Gastro-resistance and intestinal absorption of Sucrosomial® iron. (A) Gastro-resistant properties of Sucrosomial® iron compared to a sucrester-free iron preparation in an in-vitro simulated gastric fluid digestion at pH 1.2. (B) The involvement of M cells in Sucrosomial® iron uptake was evaluated using an in vitro CACO2/RajiB co-culture. The iron to protein ratio was significantly increased in co-culture cells treated with Sucrosomial® iron (SI), compared to other oral iron formulations: ferrous sulfate (FS), ferrous ascorbate (FeASC), ferrous ethylene-diamine-tetra-acetate (FeEDTA), ferrous bisglycinate (FeBIS), and control (no iron) (data are mean ± SEM, * p < 0.05) (Adapted from references [41,42]).](https://figures.cochat.ai/paper-figures/83fa6be5e09541909c5e01b4a5810dae/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-4.jpg)
![Figure 5 Bioavailability experiments on CACO-2 cells. Ferritin expression by cells treated with Sucrosomial® iron (SI) was significantly increased, compared to cells treated with ferrous sulfate (FS), phospholipid containing ferric pyrophosphate (Lipofer®), or micronized, dispersible ferric pyrophosphate (SunActive®) (A) or different iron salts, FS, ferric pyrophosphate (FePYR), ferrous ascorbate (FeASC), ferrous ethylene-diamine-tetra-acetate (FeEDTA), ferrous bisglycinate (FeBIS), and control (no iron) (B) (Data are mean ± SEM, * p < 0.001 SI vs. other iron compounds) (Adapted from references [41,45]).](https://figures.cochat.ai/paper-figures/90057c5c3069409ba253d8732f1c9c9f/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-5.jpg)
![Figure 6 Iron supplementation in anemic piglets and mice. (A) Hemoglobin concentration in anemic piglets treated with iron dextran (FeDEX) or Sucrosomial® iron (SI) (Data are mean ± SD; * p < 0.001, treatment vs. anemic; ** p < 0.001, SI vs. FeDEX). (B) Change in hemoglobin levels in anemic mice after a 14-day treatment with Sucrosomial® iron (SI) or ferrous sulfate (FS). (Data are mean ± SD; * p < 0.01, SI or FS vs. saline; ** p < 0.05, FS vs. vehicle) (Adapted from references [46,47]).](https://figures.cochat.ai/paper-figures/5c74524764144e00aff389f257b54e0b/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-6.jpg)
![Figure 7 Comparative efficacy of different oral iron formulations for treating bleeding-induced moderate-to-severe anemia. SunActive®, micronized ferric pyrophosphate. Each oral iron formulation was tested in 60 patients (Data taken from reference [89]).](https://figures.cochat.ai/paper-figures/9eb6a9b1ed3d4d498f2347d5433eb672/sucrosomial-iron-a-new-generation-iron-for-improving-oral-supplementation-figure-7.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Pre-clinical data indicate that it may be more tolerable than other oral iron formulations whilst having similar effectiveness at restoring iron levels [32].”
From Oral Iron Supplementation—Gastrointestinal Side Effects and the Impact on the Gut Microbiota (2021) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab670 · Cited by 19,442
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
A systematic analysis of global anemia burden from 1990 to 2010
Kassebaum, N. J., Jasrasaria, R., Naghavi, M., Wulf, S. K., Johns, N., Lozano, R., Regan, M., Weatherall, D., Chou, D. P., Eisele, T. P., et al. (2014) · Blood · doi:10.1182/blood-2013-06-508325 · Cited by 2,075
ACG Clinical Guidelines: Diagnosis and Management of Celiac Disease
Rubio-Tapia, A., Hill, I. D., Kelly, C. P., Calderwood, A. H., & Murray, J. A. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.79 · Cited by 1,681
Camaschella, C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1401038 · Cited by 1,678 · cited 3×
“In turn, hepcidin binds ferroportin, especially at the enterocytes, promoting its internalization and degradation, thus preventing iron absorption, while iron recirculation from macrophages seems to be less affected [4,14,55].”
BackgroundHepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
Ganz, T. (2003) · Blood · doi:10.1182/blood-2003-03-0672 · Cited by 1,544 · cited 2×
“In turn, hepcidin binds ferroportin, especially at the enterocytes, promoting its internalization and degradation, thus preventing iron absorption, while iron recirculation from macrophages seems to be less affected [4,14,55].”
BackgroundClinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage
Carson, J. L., Guyatt, G., Heddle, N. M., Grossman, B. J., Cohn, C. S., Fung, M. K., Gernsheimer, T., Holcomb, J. B., Kaplan, L. J., Katz, L. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.9185 · Cited by 1,113
International consensus statement on the peri‐operative management of anaemia and iron deficiency
Muñoz, M., Acheson, A. G., Auerbach, M., Besser, M., Habler, O., Kehlet, H., Liumbruno, G. M., Lasocki, S., Meybohm, P., Rao Baikady, R., et al. (2017) · Anaesthesia · doi:10.1111/anae.13773 · Cited by 876
Research works printed but not linked: 11
- Starzynski, 2017, Comparison of the therapeutical potential of oral Sucrosomial® iron and parenteral iron dextran supplementations in neonatal iron deficiency anemia in pigs, Am. J. Hematol., 92, E286
- Brilli, E., Barnadas, R., Camacho, M., Giordano, G., and Tarantino, G. (2018, January 8–11). Sucrosomial® Iron Absorption Involves M Cells Interaction. Proceedings of the European Iron Club Annual Meeting, Zürich, Switzerland.
- Berardi, 2016, Efficacy of oral Sucrosomial® iron in puerperium anemia, Exp. Rev. Hematol., 9, 40
- Barni, 2017, Upfront use of Sucrosomial® iron prevents transfusions in cancer patients on chemotherapy, Support. Care Cancer, 25, S144
- Bastida, 2016, Efficacy and tolerability of Sucrosomial iron supplementation in IBD patients with iron deficiency anemia and intolerance to iron oral salts, Exp. Rev. Hematol., 9, 6
- Stuklov, N.I., Basiladze, I.G., Pivnik, A.V., Knyazev, O.V., and Parfenov, A.I. (2018). Characteristics and modern treatment of iron deficiency syndromes in inflammatory bowel diseases. Exp. Rev. Hematol., 10, in press.
- Farinati, F., and Maddalo, G. (2018). Iron and/or B12 deficient anemia in autoimmune gastritis. High dose sucrosomial iron supplementation: Preliminary data of a single center experience. Exp. Rev. Hematol., 10, in press.
- Shipton, 2018, Deficiencies of vitamin B12, folate and iron over 4 years of follow-up post-bariatric surgery [abstract], Br. J. Surg., 105, 28
- Karavidas, A., Trogkanis, E., Farmakis, D., Papingiotis, G., Matzaraki, V., Perpinia, A., and Parissis, J. (2018). Oral sucrosomial iron improves quality of life in heart failure patients with iron deficiency: A preliminary proof-of-concept study. Exp. Rev. Hematol., 10, in press.
- Cabrera, P., Gómez, S., Herrero, V., Martín, E., Pavía, J., and Muñoz, M. (2016, January 2–3). Prevalence and consequences of anaemia among patients hospitalised at the internal medicine ward: A single centre audit. Proceedings of the 15th European Congress of Internal Medicine, Amsterdam, The Netherlands.
- Giordano, 2016, Reduction of inflammatory markers with liposomal iron (Sideral®). Pre-clinical and clinical results, Exp. Rev. Hematol., 9, S17
Cited by
Items 101–157 of 157
Iron Surveillance and Management in Gastro-Intestinal Oncology Patients: A National Physician Survey
Richard, E. S., Hrycyshyn, A., Salman, N., Tharani, A. R., Abbruzzino, A., Smith, J. L., Kachura, J. J., Sholzberg, M., Mosko, J. D., Chadi, S. A., et al. (2023) · Current Oncology · doi:10.3390/curroncol30110714 · Cited by 1
Characteristics of iron-containing dietary products on the Serbian market
Zrnić-Ćirić, M., Mijović, M., & Vidović, B. B. (2023) · Hrana i ishrana · doi:10.5937/hraish2301014z · Cited by 1
Obesity and iron deficiency: what is the connection and how to treat?
Федорова, Т. А., Strelnikova, E. V., & Gurbanova, S. R. (2024) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2024-481 · Cited by 1
Wang, X., Lipiński, P., Ogłuszka, M., Mazgaj, R., Woliński, J., Szkopek, D., Zaworski, K., Kopeć, Z., Żelazowska, B., Tarantino, G., et al. (2025) · Food & Function · doi:10.1039/d4fo04806g · Cited by 1
Self-citationGiordano, G., Bochicchio, M. T., Niro, G., Lucchesi, A., & Napolitano, M. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152297 · Cited by 1
Suva, M. A., & Tirgar, P. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0005 · Cited by 1
Effect of Several Iron Drops with Different Dilutions on Color and Structure of Primary Teeth
Farzandi, N., Farnia, F., Aghaei, S., Saati, K., & Tavassoli-Hojjati, S. (2026) · Journal of Research in Dental and Maxillofacial Sciences · doi:10.66224/jrdms.11.2.156 · Cited by 1
Günther, K. (2021) · Springer eBooks · doi:10.1007/978-3-662-61346-7_10 · Cited by 1
Günther, K. (2023) · Springer eBooks · doi:10.1007/978-3-662-65608-2_10 · Cited by 1
Peroralni preparati željeza u prevenciji i liječenju sideropenične anemije u dječjoj dobi
Đurović, I., & Rešić, A. (2023) · Hrvatski časopis zdravstvenih znanosti · doi:10.48188/hczz.3.1.7 · Cited by 1
Different forms of iron therapy in the treatment of iron deficiency anemia in children
Elgawad, A. Z. A., Elaskary, E. M., Elkholy, R. A., & Hagag, A. A. E. (2023) · International Journal of Pediatrics and Neonatology · doi:10.33545/26648350.2023.v5.i2b.56 · Cited by 1
Significance of Different Salts in Nutritional Supplementation After Metabolic and Bariatric Surgery
Palaniappan, R., Siam, M., Khokhare, B., & Krishna, N. (2025) · Springer eBooks · doi:10.1007/978-981-96-5099-6_11
Moving anemia needle: Imperatives of integrative approaches
Arora, N. K., & Goteti, H. N. (2023) · Journal of Integrative Medicine and Public Health · doi:10.4103/jimph.jimph_10_23
Jans, K., Huebbe, P., Kipp, A. P., & Rimbach, G. (2026) · BioFactors · doi:10.1002/biof.70115
Makarova, N. A. (2024) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2024-102-5-6-454-467
Gurkina, A. A., Стуклов, Н. И., Kokorin, K. V. A., Рашитович, Г. Р., & Varekha, N. V. (2025) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2025-103-2-129-136
Ouafa, Y. E., Mourabiti, I., Abdi, N. E., Fadi, M., Benrahma, H., & Bouanani, N. (2026) · Cureus · doi:10.7759/cureus.112040
Iron Dyshomeostasis in Schizophrenia and Potential Treatments to Mitigate Its Effects
Okafor, S. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/9781837672059-00080
Prescribing challenges following bariatric surgery
Waldock, C., & Bedford, D. (2019) · Journal of Prescribing Practice · doi:10.12968/jprp.2019.1.9.440
An Audit on Anaemia in Pregnancy Treatment in a Local Health Clinic
Shalihin, M. S. E., Hisham, M. A. B. M., Hadi, N. A. B. R. A., & Hisham, N. I. N. B. M. (2023) · Borneo Journal of Medical Sciences (BJMS) · doi:10.51200/bjms.v17i3.4342
Pepi, S., Talarico, L., Leone, G., Bonechi, C., Tamasi, G., Clemente, I., Consumi, M., Bisozzi, F., Ietta, F., Rossi, C., et al. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105535
EFFICACY AND TOLERABILITY OF DIFFERENT ORAL IRON PREPARATIONS IN IRON DEFICIENCY ANEMIA: REVIEW
Holoborodko, A. D., Wieczorkiewicz, E., Stępińska, P., Garbacz, E., Pocheć, A., Lautenbach, B., Nędza, D., Wojciech, K., Loputs, A., & Błaszczyk, W. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.4614
Iron homeostasis at the interface of nutrition, infection, and iron supplementation
Mert, Ö., Saday, S., & Temel, A. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1943495
Eisenmangelanämie bei gastrointestinalen Erkrankungen ist multifaktoriell
Stein, J. M., & Farrag, K. (2020) · Gastro-News · doi:10.1007/s15036-020-1322-9
Anémie à la sortie de réanimation pédiatrique : prévalence, marqueurs de risque et prise en charge
Demaret, P. (2020) · theses.fr (ABES) · doi:10.70675/9f43b8dfz2d19z4048zb4a2z2d5ac9df5190
Taghipur, G., Lashkarizadeh, M., Askari, P. S., Ahmadinia, H., & Parizi, M. K. (2020) · مجله علمی دانشگاه علوم پزشکی رفسنجان · doi:10.29252/jrums.19.9.995
Liy‐Wong, C., Tarango, C., Pope, E., Coates, T. D., Bruckner, A. L., Feinstein, J. A., Schwieger‐Briel, A., Hubbard, L. D., Jane, C., Torres-Pradilla, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570959
Liy‐Wong, C., Tarango, C., Pope, E., Coates, T. D., Bruckner, A. L., Feinstein, J. A., Schwieger‐Briel, A., Hubbard, L. D., Jane, C., Torres-Pradilla, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26570962
Patient blood management in pregnancy, the peripartum, and the postpartum period
Filho, A. L. D. S., Alves, Á. L. L., & Osanan, G. C. (2026) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.61622/rbgo/2026fps7
Patient Blood Management na gravidez, no periparto e no pós-parto Número 7 – 2026
Filho, A. L. D. S., Alves, Á. L. L., & Osanan, G. C. (2026) · Femina · doi:10.61622/0100-7254545202605
Guimarães, A., Leal, T., Carvalho, T., Mendes, S., Gonçalves, A., Leal, C., Santos, A., Arroja, B., Rebelo, A., Costa, J. D. E., et al. (2025) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000549682
Hierro sucrosomado: tolerancia y efectividad en el tratamiento de la deficiencia de hierro (HS-ETFe)
Vilaseca, A., Almonacid, C., Barbera, R., Rossi, A., & Puente, D. (2025) · Revista Hematología · doi:10.48057/hematologa.v29i2.640
Iron Oxide Nanoparticles Integrated in 3D-Printed Dosage Forms for Advanced Iron Supplementation
Santos, M.-K. M. S., Santos, A. S., Silveira, A. P., Sousa-Moura, D., Gross, I. P., da Silva, I. G. M., Muehlmann, L. A., Grisólia, C. K., Silva, S. W. D., Báo, S. N., et al. (2026) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.5c00159
ANEMIA IN INFLAMMATORY BOWEL DISEASE: ETIOLOGY, PATHOGENESIS, DIAGNOSIS, TREATMENT
Богданов, А. Н., Волошин, С. В., & Кулибаба, Т. Г. (2023) · University therapeutic journal · doi:10.56871/utj.2023.18.82.003
Федорова, Т. А., Strelnikova, E. V., & Khamidulina, K. G. (2024) · Medical alphabet · doi:10.33667/2078-5631-2024-19-16-20
BRIOSCHI, M., Pagliari, S., Capietti, M., Madini, N., Santero, S., Cena, H., Magri, F., & Campone, L. (2026) · BOA (University of Milano-Bicocca)
Buchalik, K., Polewka, M., & Czempik, P. F. (2026) · Journal of Transfusion Medicine and Hemostasis · doi:10.5603/jtm.105025
Buchalik, K., Polewka, M., & Czempik, P. F. (2026) · Journal of Transfusion Medicine and Hemostasis · doi:10.5603/jtm.104465
A review – Prescribing iron salts: Comparison of efficacy and tolerance of different iron complexes
Snyman, K. R., Snyman, J., & Coetzee, A. (2026) · South African Family Practice · doi:10.4102/safp.v68i1.6260
Патофизиология анемического синдрома при целиакии и его терапевтическое лечение
Саварбековна, О. Л., Ledentsova, S. S., Васильевич, С. П., Петровна, С. С., & Сергеевна, И. Е. (2023) · Medical alphabet
Oral ve Parenteral Demir Preparatları ve Pratik Kullanımları
Ayyıldız, O., & Bağcıer, S. P. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.2895.c2151
Soriano‐Lerma, A. (2023) · Institutional Repository of the University of Granada (University of Granada)
Güncel pediatri : = Journal of current pediatrics
(n.d.) · RWTH Publications (RWTH Aachen)
Liposomi u liječenju sideropenične anemije
Baburić, A. (2019) · Repozitorij Farmaceutsko-biokemijskog fakulteta (Sveučilišta u Zagrebu)
Анемия хронических заболеваний
Васильевна, О. Н., & Джимшеровна, К. Н. (2024) · Medical alphabet
Bano, A., Abrar, S., Brilli, E., Tarantino, G., Bugti, A. A., Fabbrini, M., Conti, G., Turroni, S., Bugti, M., Afridi, F., et al. (2023) · doi:10.3389/fnut.2023.1221685.s002
Self-citationAstori, E. (2021) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/astori-emanuela_phd2021-02-23
Orlova, P. D., Meshkov, I. B., Latipov, E. V., Vasiliev, S. G., Калинина, А. А., Muzafarov, A. M., & Le‐Deygen, I. M. (2024) · Журнал неорганической химии · doi:10.31857/s0044457x24040143
Hipofosfatemia tras la administración de hierro intravenoso: Causas, consecuencia y profilaxis
Meijide, H. (2025) · Galicia Clínica · doi:10.22546/85/3/1349
Comparison of Iron-Based Supplements and their Possible Use in Adjuvant Therapy in Oncology Patients
Riccardi, B. (2025) · Journal of Food Technology & Nutrition Sciences · doi:10.47363/jftns/2025(7)202
Αναιμία στη χρόνια νεφρική νόσο
Κολοβού, Μ. Σ. (2022) · University of Thessaly Institutional Repository (University of Thessaly) · doi:10.26253/heal.uth.37491
Primerjava izbranih postopkov (mikro)kapsuliranja železa
Jaklič, L. (2024) · Repository of the University of Ljubljana (University of Ljubljana)
Islamov, J. (2026) · Eurasian Journal of Medical and Natural Sciences · doi:10.70413/ejmns-v06-i04-s48767
Güngör, E. A., & Topal, B. G. (2026) · Güncel Pediatri · doi:10.4274/jcp.2025.93609
Patient Blood Management in Orthopedic Surgery
Monteith, K. E., Cahill, C. M., Bunnell, B. E., LaPointe, D. L., & Gloff, M. S. (2026) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000522
Maharajan, V., Jones, N. R., Bankhead, C. R., Erone, I., Haynes, S., Katumba, A. M., Li, C. K. H., Maynard, S., Roy, N., Shah, A., et al. (2026) · medRxiv · doi:10.64898/2026.06.14.26355620
Анатольевна, Ф. Т., Владимировна, С. Е., & Геннадьевна, Х. К. (2024) · Medical alphabet
Metadata
- Authors
- Gómez-Ramírez, S., Brilli, E., Tarantino, G., & Muñoz, M.
- Affiliations
- Department of Internal Medicine, University Hospital Virgen de la Victoria. Campus de Teatinos, 2010 Málaga, Spain
- Scientific Department, Alesco S.r.l. Via delle Lenze, 216/B, 56122 Pisa, Italy
- PharmaNutra SpA (Italy) (IT)
- Perioperative Transfusion Medicine, Department of Surgical Specialties, Biochemistry and Immunology, School of Medicine, Campus de Teatinos, 29071 Málaga, Spain
- Venue
- Pharmaceuticals
- Publisher
- MDPI AG
- Published
- 2018-10-04
- Volume
- 11
- Issue
- 4
- Pages
- 97
- ISSN
- 1424-8247 (ISSN-L)
- PMC
- PMC6316120
- OpenAlex
- W2895639972
- Cited by
- 132
- References
- 82
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 28 · 2023: 19 · 2022: 14 · 2021: 20 · 2020: 17 · 2019: 7 · 2018: 1
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceuticals (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- sucrosomial iron, oral iron supplementation, iron deficiency, ferric pyrophosphate, phospholipid bilayers, M cells, iron bioavailability, gastrointestinal tolerance, chronic kidney disease, cancer patients, bariatric surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.